SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-25-002035
Filing Date
2025-01-08
Accepted
2025-01-08 16:18:24
Documents
15
Period of Report
2025-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252686d1_8k.htm   iXBRL 8-K 33251
2 EXHIBIT 99.1 tm252686d1_ex99-1.htm EX-99.1 38699
6 GRAPHIC tm252686d1_ex99-1img01.jpg GRAPHIC 4707
  Complete submission text file 0001104659-25-002035.txt   262850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20250108.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20250108_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20250108_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm252686d1_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 25518756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)